Anti-Obesity Drugs Projected to Drive 2024 Drug Spending
Anti-obesity drugs, especially semaglutide and tirzepatide, accounted for the majority of endocrine drug expenditure growth in 2023.
Source: endocrinologyadvisor.com
Sales Perspective News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sales Perspective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sales Perspective Today - Breaking & Trending Today
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA's Doug Long
Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Source: ajmc.com
Biden-Harris Administration Marks Two Years of Advancements in HHS' Overdose Prevention Strategy with New Actions to Treat Addiction and Save Lives
Biden-Harris Administration Marks Two Years of Advancements in HHS’ Overdose Prevention Strategy
Source: hhs.gov
Prescriptions for Chronic Conditions Underused in U.S. Jails, Prisons
FRIDAY, April 28, 2023 (HealthDay News) -- Prescription medications for chronic conditions are substantially underused in U.S. jails and state prisons, according to a study published online April 14 in
Source: vtcng.com
Asthma, other chronic conditions undertreated among incarcerated patients
Patients with asthma and other chronic illnesses in jail and prison in the United States may be undertreated compared with the general population, according to a study published in JAMA Health Forum. These findings indicate an opportunity to improve the health of people who are incarcerated in the U.S., Jill Curran, MS, research program manager, Johns Hopkins Bloomberg School of Public Health,
Source: healio.com